Advanced search
Publication Cover
Infection and Drug Resistance Volume 14, 2021 - Issue
Submit an article Journal homepage
139
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of sTREM1 and suPAR Biomarkers as Diagnostic and Prognostic Predictors in Sepsis Patients

Asmaa Nasr El-Din1 Department of Microbiology and Immunology, Faculty of Medicine, Sohag University, Sohag, EgyptCorrespondence[email protected]
,
Abdelhady Ragab Abdel-Gawad2 Department of Clinical and Chemical Pathology, Faculty of Medicine, Sohag University, Sohag, EgyptORCID Iconhttps://orcid.org/0000-0002-2574-9953
ORCID Icon,
Wesam Abdelgalil3 Departments of Anesthesia and Intensive Care, Faculty of Medicine, Sohag University, Sohag, Egypt
&
Nahed F Fahmy1 Department of Microbiology and Immunology, Faculty of Medicine, Sohag University, Sohag, EgyptORCID Iconhttps://orcid.org/0000-0001-9688-635X
ORCID Icon
Pages 3495-3507 | Published online: 31 Aug 2021

References

  • Henriquez-CamachoC, LosaJ. Biomarkers for sepsis. Bio Med Res Int. 2014;ID 547818:1–6.
  • BalkR. The evolving paradigms of sepsis. Contrib Microbiol. 2011;17:1–11.21659744
  • FaixJD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013;50(1):23–36. doi:10.3109/10408363.2013.76449023480440
  • GodnicM, StubjarD, SkvarcM, JukicT. Diagnostic and prognostic value of sCD14‑ST presepsin for patients admitted to hospital intensive care unit. Wien Klin Wochenschr. 2015;127:521–527. doi:10.1007/s00508-015-0719-525854904
  • BironBM, AyalaA, Lomas-NeiraJL. Biomarkers for sepsis: what is and what might be?Biomark Insights. 2015;10(4):7–17.26417200
  • AtallaHA, AbdelazizAA, RagabAM. Biomarkers in sepsis: review article. Menoufia Med J. 2018;31(4):1110–1115.
  • EricksonSE, MartinGS. Effect of sepsis therapies on health‑related quality of life. Crit Care. 2008;12(1):109. doi:10.1186/cc621518254930
  • WangB, ChenG, ZhangJ, XueJ, CaoY, WuY. Increased neutrophil gelatinase associated lipocalin is associated with mortality and multiple organ dysfunction syndrome in severe sepsis and septic shock. Shock. 2015;44(3):234–238. doi:10.1097/SHK.000000000000040826009825
  • JedynakM, SiemiatkowskiA, MroczkoB, GroblewskaM, MilewskiR, SzmitkowskiM. Soluble TREM-1 serum level can early predict mortality of patients with sepsis, severe sepsis and septic shock. Arch Immunol Ther Exp. 2018;66(4):299–306. doi:10.1007/s00005-017-0499-x
  • CaoC, GuJ, ZhangJ. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases. Front Med. 2017;11(2):169–177. doi:10.1007/s11684-017-0505-z28425045
  • GustafssonA, LjunggrenL, BodelssonM, BerkestedtI. The prognostic value of suPAR compared to other inflammatory markers in patients with severe sepsis. Biomark Insights. 2012;7:39–44. doi:10.4137/BMI.S946022550400
  • JedynakM, SiemiatkowskiA, MilewskiR, MroczkoB, SzmitkowskiM. Diagnostic effectiveness of soluble triggering receptor expressed on myeloid cells-1 in sepsis, severe sepsis and septic shock. Arch Med Sci. 2019;15(3):713–721. doi:10.5114/aoms.2018.7309031110539
  • ŞenS, KamitF, IşgüderR, et al. Surface TREM-1 as a prognostic biomarker in pediatric sepsis. Indian J Pediatr. 2021;88(2):134–140. doi:10.1007/s12098-020-03355-332572693
  • LeeCC, HongMY, LeeNY, ChenPL, ChangCM, KoWC. Pitfalls in using serum C-reactive protein to predict bacteremia in febrile adults in the ED. Am J Emerg Med. 2012;30(4):562–569. doi:10.1016/j.ajem.2011.02.01221514766
  • Rivera-ChavezFA, MineiJP. Soluble triggering receptor expressed on myeloid cells-1 is an early marker of infection in the surgical intensive care unit. Surg Infect (Larchmt). 2009;10(5):435–439. doi:10.1089/sur.2009.03019792836
  • SuL, HanB, LiuB, et al. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis. 2012;12:157. doi:10.1186/1471-2334-12-15722809118
  • OkuR, OdaS, NakadaT, et al. Differential pattern of cell-surface and soluble TREM-1 between sepsis and SIRS. Cytokine. 2013;61(1):112–117. doi:10.1016/j.cyto.2012.09.00323046618
  • ChangW, PengF, MengSS, XuJY, YangY. Diagnostic value of serum soluble triggering expressed receptor on myeloid cells 1 (sTREM-1) in suspected sepsis: a meta-analysis. BMC Immunol. 2020;21(2):1–3. doi:10.1186/s12865-020-0332-x31898481
  • ZhangJ, SheD, FengD, JiaY, XieL. Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study. BMC Infect Dis. 2011;11:53. doi:10.1186/1471-2334-11-5321356122
  • LiZ, WangH, LiuJ, ChenB, LiG. Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: a prospective cohort study. Mediators Inflamm. 2014;ID 641039:7.
  • ZhangL, ZhangX. Serum sTREM-1, PCT, CRP, Lac as biomarkers for death risk within 28 days in patients with severe sepsis. Open Life Sci. 2018;13:42–47. doi:10.1515/biol-2018-000633817066
  • Giamarellos-BourboulisEJ, Norrby-TeglundA, MylonaV, et al. Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor. Crit Care. 2012;16(4):149–159. doi:10.1186/cc1146322963733
  • KochA, VoigtS, KruschinskiC, et al. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care. 2011;15(1):R63. doi:10.1186/cc1003721324198

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.